Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Healthtrust
US Army
Baxter
QuintilesIMS
McKinsey
Moodys
Harvard Business School
Argus Health

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,804,666

« Back to Dashboard

Summary for Patent: 4,804,666
Title: Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridin es
Abstract:Derivatives of 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, and pharmaceutically acceptable salts and solvates thereof are disclosed, which possess anti-allergic activity, making them effective as anti-allergic compounds. Methods for preparing and using the compounds are also described.
Inventor(s): Piwinski; John J. (Parsippany, NJ), Green; Michael J. (Skillman, NJ), Ganguly; Ashit K. (Upper Montclair, NJ), Wong; Jesse K. (Union, NJ), Katchen; Bernard (Livingston, NJ), Cramer; Jeffrey (Westfield, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:07/043,409
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,804,666
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 4,804,666

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 4,804,666

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece 3006483 ➤ Try a Free Trial
Hong Kong 135595 ➤ Try a Free Trial
Hungary 202520 ➤ Try a Free Trial
Canada 1332172 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
QuintilesIMS
Chinese Patent Office
Queensland Health
Julphar
UBS
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.